GetFundedUSA

GetFundedUSA › Grants › General › NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)

NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)

General · National Institutes of Health · Nationwide

General grant
Not reportedaward range
openstatus
Jul 05, 2029 12:00:00 AM EDTdeadline
Nationwidecoverage

This is a National Institutes of Health cooperative agreement, sponsored by NIDCR, that funds investigator-initiated observational or biomarker validation studies requiring prospective data collection, open to eligible U.S.-based applicants with a deadline listed as July 5, 2029.

This listing covers a Notice of Funding Opportunity (NOFO) from the National Institutes of Health (NIH), issued through the National Institute of Dental and Craniofacial Research (NIDCR), for a Cooperative Agreement titled "Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)."

According to the official summary, this funding opportunity supports investigator-initiated observational studies or biomarker validation studies that require prospective collection of data or biospecimens, or continued analysis of existing data or biospecimens. This is a cooperative agreement, meaning NIH staff are substantially involved in the funded project, not just a hands-off grant.

The funding mechanism is a U01 award, and clinical trials are explicitly not allowed under this NOFO. This distinguishes it from other NIH funding opportunities that do support trial-based research.

Eligible applicants are directed to review Section III of the NOFO for full eligibility details. What is specified here is that foreign (non-U.S.) organizations are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components as defined in the NIH Grants Policy Statement are not allowed. Eligible states are listed as all U.S. states.

No award floor, ceiling, or specific dollar amount is provided in the available data, so applicants should confirm funding levels directly through the official NOFO. The deadline listed is July 5, 2029, though applicants should verify this date and any earlier internal deadlines at the source.

This opportunity may be relevant to small business owners only if they operate as research entities or contractors capable of conducting NIH-funded observational or biomarker research; it is not a general small-business grant. Full details, eligibility criteria, and application requirements should be confirmed at the official grants.gov listing before proceeding.

Who qualifies

Eligibility details are primarily deferred to Section III of the official NOFO, but the data specifies that foreign (non-U.S.) organizations, non-domestic components of U.S. organizations, and foreign components as defined in the NIH Grants Policy Statement are not eligible to apply. Eligible states are listed as all U.S. states. Confirm eligibility at the official source for full applicant requirements.

How to apply

1. Review the full Notice of Funding Opportunity (NOFO) for detailed eligibility, requirements, and submission instructions. 2. Confirm the application deadline and any internal review dates directly on the official listing. 3. Prepare and submit your application through Grants.gov. 4. Apply here: https://www.grants.gov/search-results-detail/359946

Apply on National Institutes of Health ↗

View original source ↗

Questions people ask

Is this a grant or a loan?

It is a cooperative agreement (U01), a type of federal funding award, not a loan.

Do I have to repay this funding?

Cooperative agreements are not loans, so repayment in the traditional sense is not indicated; confirm specific terms at the official source.

Who runs this program?

The National Institutes of Health (NIH), specifically through its NIDCR institute, sponsors this opportunity.

What does this funding support?

It supports investigator-initiated observational studies or biomarker validation studies requiring prospective data/biospecimen collection or continued analysis.

Are clinical trials allowed under this funding?

No, this NOFO explicitly states that clinical trials are not allowed.

Who is eligible to apply?

Full eligibility is detailed in Section III of the NOFO; foreign organizations and foreign components are not eligible.

Can foreign organizations apply?

No, non-domestic entities, non-domestic components of U.S. organizations, and foreign components are not eligible.

What states are eligible?

All U.S. states are eligible.

How much funding is available?

No award floor, ceiling, or amount is specified in the available data; confirm at the official source.

What is the deadline to apply?

The listed deadline is July 5, 2029, but applicants should confirm this and any earlier internal deadlines at the source.

Where do I apply?

Applications are submitted through Grants.gov at https://www.grants.gov/search-results-detail/359946.

Is this funding taxable?

This is not addressed in the available data; confirm at the official source.

What type of organizations does this suit?

It suits research entities capable of conducting NIH-funded observational or biomarker validation studies, not general small businesses.

Opportunity number: PAR-27-058. Source: grants.gov. GetFundedUSA is independent and not affiliated with National Institutes of Health; always confirm current deadlines, amounts and eligibility on the sponsor's own page before applying.